RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Predictors of Recovery of Left Ventricular Systolic Dysfunction after Acute Myocardial Infarction: From the Korean Acute Myocardial Infarction Registry and Korean Myocardial Infarction Registry

      한글로보기

      https://www.riss.kr/link?id=A104685917

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background and Objectives: We investigated the predictors of the recovery of depressed left ventricular ejection fraction (LVEF) in pa-tients with moderate or severe left ventricular (LV) systolic dysfunction after acute myocardial infarction (MI). S...

      Background and Objectives: We investigated the predictors of the recovery of depressed left ventricular ejection fraction (LVEF) in pa-tients with moderate or severe left ventricular (LV) systolic dysfunction after acute myocardial infarction (MI).
      Subjects and Methods: We analyzed 1307 patients, who had moderately or severely depressed LVEF (<45%) on echocardiography soon after acute MI and who underwent a follow-up echocardiography, among 27369 patients from the Korea Working Group on the Myocar-dial Infarction Registry. Patients were categorized into two groups according to recovery of LVEF: group I with consistently depressed LVEF (<45%) at the follow-up echocardiography and group II with a recovery of LVEF (≥45%).
      Results: Recovery of LV systolic dysfunction was observed in 51% of the subjects (group II, n=663; ΔLVEF, 16.2±9.3%), whereas there was no recovery in the remaining subjects (group I, n=644; ΔLVEF, 0.6±7.1%). In the multivariate analysis, independent predictors of recovery of depressed LVEF were as follows {odds ratio (OR) [95% confidence interval (CI)]}: moderate systolic dysfunction {LVEF ≥30% and <45%;1.73 (1.12-2.67)}, Killip class I-II {1.52 (1.06-2.18)}, no need for diuretics {1.59 (1.19-2.12)}, non-ST-segment elevation MI {1.55 (1.12-2.16)},lower peak troponin I level {<24 ng/mL, median value; 1.55 (1.16-2.07)}, single-vessel disease {1.53 (1.13-2.06)}, and non-left anterior descending (LAD) culprit lesion {1.50 (1.09-2.06)}. In addition, the use of statin was independently associated with a recovery of LV systolic dysfunction {OR (95% CI), 1.46 (1.07-2.00)}.
      Conclusion: Future contractile recovery of LV systolic dysfunction following acute MI was significantly related with less severe heart failure at the time of presentation, a smaller extent of myonecrosis, or non-LAD culprit lesions rather than LAD lesions.

      더보기

      참고문헌 (Reference)

      1 Gibbons RJ, "The quantification of infarctsize" 44 : 1533-1542, 2004

      2 Kjekshus J, "The effectsof simvastatin on the incidence of heart failure in patients withcoronary heart disease" 3 : 249-254, 1997

      3 Horwich TB, "Statin therapy is associatedwith improved survival in ischemic and non-ischemic heart failure" 43 : 642-648, 2004

      4 "Risk stratification and survival after myocardial infarction" 309 : 331-336, 1983

      5 Steen H, "Relativerole of NT-pro BNP and cardiac troponin T at 96 hours for estimationof infarct size and left ventricular function after acute myocardial infarction" 9 : 749-758, 2007

      6 Solomon SD, "Recovery of ventricular functionafter myocardial infarction in the reperfusion era: the healing andearly afterload reducing therapy study" 134 : 451-458, 2001

      7 Lang RM, "Recommendations for chamberquantification: a report from the American Society of Echocardiography’sGuidelines and Standards Committee and the Chamber QuantificationWriting Group, developed in conjunction with the European Associationof Echocardiography, a branch of the European Society ofCardiology" 18 : 1440-1463, 2005

      8 St John Sutton M, "Quantitative two-dimensionalechocardiographic measurements are major predictors ofadverse cardiovascular events after acute myocardial infarction. Theprotective effects of captopril" 89 : 68-75, 1994

      9 Gaudron P, "Progressive left ventricular dysfunctionand remodeling after myocardial infarction. Potential mechanismsand early predictors" 87 : 755-763, 1993

      10 Auerbach MA, "Prevalence of myocardial viabilityas detected by positron emission tomography in patients with ischemiccardiomyopathy" 99 : 2921-2926, 1999

      1 Gibbons RJ, "The quantification of infarctsize" 44 : 1533-1542, 2004

      2 Kjekshus J, "The effectsof simvastatin on the incidence of heart failure in patients withcoronary heart disease" 3 : 249-254, 1997

      3 Horwich TB, "Statin therapy is associatedwith improved survival in ischemic and non-ischemic heart failure" 43 : 642-648, 2004

      4 "Risk stratification and survival after myocardial infarction" 309 : 331-336, 1983

      5 Steen H, "Relativerole of NT-pro BNP and cardiac troponin T at 96 hours for estimationof infarct size and left ventricular function after acute myocardial infarction" 9 : 749-758, 2007

      6 Solomon SD, "Recovery of ventricular functionafter myocardial infarction in the reperfusion era: the healing andearly afterload reducing therapy study" 134 : 451-458, 2001

      7 Lang RM, "Recommendations for chamberquantification: a report from the American Society of Echocardiography’sGuidelines and Standards Committee and the Chamber QuantificationWriting Group, developed in conjunction with the European Associationof Echocardiography, a branch of the European Society ofCardiology" 18 : 1440-1463, 2005

      8 St John Sutton M, "Quantitative two-dimensionalechocardiographic measurements are major predictors ofadverse cardiovascular events after acute myocardial infarction. Theprotective effects of captopril" 89 : 68-75, 1994

      9 Gaudron P, "Progressive left ventricular dysfunctionand remodeling after myocardial infarction. Potential mechanismsand early predictors" 87 : 755-763, 1993

      10 Auerbach MA, "Prevalence of myocardial viabilityas detected by positron emission tomography in patients with ischemiccardiomyopathy" 99 : 2921-2926, 1999

      11 Abdel-Salam Z, "Predictors of myocardial contractile recoveryafter coronary revascularization in patients with prior myocardialinfarction" 11 : 2-7, 2010

      12 Leclercq F, "Myocardial viabilityassessed by dobutamine echocardiography in acute myocardial infarctionafter successful primary coronary angioplasty" 80 : 6-10, 1997

      13 Christian TF, "Mismatch of left ventricular function and infarct size demonstratedby technetium-99m isonitrile imaging after reperfusion therapy foracute myocardial infarction: identification of myocardial stunning andhyperkinesia" 16 : 1632-1638, 1990

      14 Ottervanger JP, "Long-term recovery ofleft ventricular function after primary angioplasty for acute myocardialinfarction" 22 : 785-790, 2001

      15 White HD, "Left ventricular end-systolic volume as the major determinant of survivalafter recovery from myocardial infarction" 76 : 44-51, 1987

      16 Bauters C, "Late recovery in left ventricularsystolic function after discharge of patients with a first anterior myocardialinfarction" 103 : 538-545, 2010

      17 Bolognese L, "Influence of infarct-zoneviability on left ventricular remodeling after acute myocardial infarction" 96 : 3353-3359, 1997

      18 Wijns W, "Hibernating myocardium" 339 : 173-181, 1998

      19 Aronow WS, "Frequency of congestive heart failure in older personswith prior myocardial infarction and serum low-density lipoproteincholesterol > or = 125 mg/dl treated with statins versus no lipidloweringdrug" 90 : 147-149, 2002

      20 Stenestrand U, "Early statin treatment following acute myocardial infarctionand 1-year survival" 285 : 430-436, 2001

      21 Eitzman D, "Clinical outcome of patientswith advanced coronary artery disease after viability studies with positronemission tomography" 20 : 559-565, 1992

      22 Sola S, "Atorvastatin improvesleft ventricular systolic function and serum markers of inflammationin nonischemic heart failure" 47 : 332-337, 2006

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-05-15 학회명변경 한글명 : 대한순환기학회 -> 대한심장학회
      영문명 : The Korean Society Of Circulation -> The Korean Society of Cardiology
      KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-08-02 학술지등록 한글명 : Korean Circulation Journal
      외국어명 : Korean Circulation Journal
      KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2001-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.13 0.34 0.71
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.45 0.36 0.52 0.12
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼